Eli Lilly reported for 9 months of 2023

Eli Lilly and Co's GAAP net income for 9 months of 2023 was $3.051 billion, down 29.2% from $4.307 billion in the prior year. Revenue increased 16.6% to $24.77 billion from $21.24 billion a year earlier.